Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Medicure Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
MCUJF
Over the counter
8731
https://www.medicure.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Medicure Inc
Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
- Apr 23rd, 2024 9:00 pm
Medicure Full Year 2023 Earnings: CA$0.088 loss per share (vs CA$0.13 profit in FY 2022)
- Apr 13th, 2024 12:45 pm
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
- Apr 8th, 2024 9:00 pm
Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
- Apr 4th, 2024 10:00 pm
Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
- Dec 5th, 2023 10:00 pm
Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
- Nov 23rd, 2023 10:00 pm
Medicure Reports Financial Results for Quarter Ended September 30, 2023
- Nov 21st, 2023 10:00 pm
Medicure Reiterates its Commitment to Providing Exceptional Access to its Branded Pitavastatin (Zypitamag) to People Living With HIV
- Aug 29th, 2023 10:00 pm
Medicure Reports Financial Results For Quarter Ended June 30, 2023
- Jul 29th, 2023 12:00 am
Medicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023
- Jul 24th, 2023 11:00 pm
Medicure Reports Financial Results for Quarter Ended March 31, 2023
- May 26th, 2023 9:30 pm
Scroll